These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34869970)

  • 1. MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial-Mesenchymal Transition.
    Wei W; Wang L; Xu L; Liang J; Teng L
    ACS Omega; 2021 Nov; 6(47):31435-31446. PubMed ID: 34869970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition.
    Wei W; Wang J; Hu Y; Chen S; Liu J
    Exp Ther Med; 2023 Jan; 25(1):7. PubMed ID: 36545274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF-1α/miR-21 axis under hypoxic conditions in pancreatic cancer.
    Deng K; Zou F; Xu J; Xu D; Luo Z
    Mol Carcinog; 2024 Mar; 63(3):524-537. PubMed ID: 38197482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway.
    Liu QQ; Chen K; Ye Q; Jiang XH; Sun YW
    Cancer Cell Int; 2016; 16():57. PubMed ID: 27453691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of HSP27 on Gemcitabine-Resistant Pancreatic Cancer Cell Line Through Snail.
    Zhang S; Zhang XQ; Huang SL; Chen M; Shen SS; Ding XW; Lv Y; Zou XP
    Pancreas; 2015 Oct; 44(7):1121-9. PubMed ID: 26348464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.
    Zhang JQ; Chen S; Gu JN; Zhu Y; Zhan Q; Cheng DF; Chen H; Deng XX; Shen BY; Peng CH
    J Cell Biochem; 2018 Jan; 119(1):1027-1040. PubMed ID: 28685847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
    Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y
    Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulatory effect of miR-30b on migration and invasion of pancreatic cancer stem cells].
    Guo QS; Wang P; Huang Y; Guo YB; Zhu MY; Xiong YC
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(38):3019-3023. PubMed ID: 31607036
    [No Abstract]   [Full Text] [Related]  

  • 9. [The relationship between the radioresistance of pancreatic cancer cell SW1990 and the induction of the Epithelial-Mesenchymal Transition: an in vitro study].
    Jiang YH; You KY; Bi ZF; Li LT; Mo HQ; Liu YM
    Zhonghua Yi Xue Za Zhi; 2018 Mar; 98(12):939-943. PubMed ID: 29665670
    [No Abstract]   [Full Text] [Related]  

  • 10. miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1.
    Wang X; Zhou X; Zeng F; Wu X; Li H
    Breast Cancer; 2020 Jul; 27(4):765-775. PubMed ID: 32144736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-183 induces epithelial-mesenchymal transition and promotes endometrial cancer cell migration and invasion in by targeting CPEB1.
    Xiong H; Chen R; Liu S; Lin Q; Chen H; Jiang Q
    J Cell Biochem; 2018 Nov; 119(10):8123-8137. PubMed ID: 29923214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG.
    An N; Zheng B
    Technol Cancer Res Treat; 2020; 19():1533033819898729. PubMed ID: 32301392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine.
    Yu Y; Ding F; Gao M; Jia YF; Ren L
    Oncol Lett; 2019 Sep; 18(3):3065-3071. PubMed ID: 31452783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1.
    Wang J; Wang X; Liu F; Fu Y
    Pharmazie; 2017 Aug; 72(8):475-481. PubMed ID: 29441907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-30b targets Snail to impede epithelial-mesenchymal transition in pancreatic cancer stem cells.
    Xiong Y; Wang Y; Wang L; Huang Y; Xu Y; Xu L; Guo Y; Lu J; Li X; Zhu M; Qian H
    J Cancer; 2018; 9(12):2147-2159. PubMed ID: 29937934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 17. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells.
    Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Yamada T; Kudo M; Yue J; Sakuragi N
    J Exp Clin Cancer Res; 2016 Sep; 35(1):132. PubMed ID: 27596137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1.
    Chen XB; Li W; Chu AX
    J Cell Biochem; 2019 Jan; 120(1):470-480. PubMed ID: 30161272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
    Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
    Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-143-3p inhibits proliferation and invasion of hepatocellular carcinoma cells by regulating its target gene FGF1.
    Peng J; Wu HJ; Zhang HF; Fang SQ; Zeng R
    Clin Transl Oncol; 2021 Mar; 23(3):468-480. PubMed ID: 32617870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.